{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:22:53Z","timestamp":1771518173838,"version":"3.50.1"},"reference-count":56,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Vet Emergen Crit Care"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine changes in creatinine concentrations following the administration of 6% tetrastarch (hydroxyethyl starch [HES] 130\/0.4) compared to crystalloids (CRYSs) in critically ill dogs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective case series (2010\u20132013).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>University teaching hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Animals<\/jats:title><jats:p>Two hundred and one dogs admitted to the intensive care unit with initial plasma creatinine concentrations not exceeding laboratory reference intervals (52\u2013117 \u03bcmol\/L [0.6\u20131.3 mg\/dL]) and receiving either CRYSs alone (CRYS group,<jats:italic>n<\/jats:italic>= 115) or HES with or without CRYSs (HES group,<jats:italic>n<\/jats:italic>= 86) for at least 24 hours.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and Main Results<\/jats:title><jats:p>Creatinine concentrations at admission to the intensive care unit (T0), and 2\u201313 days (T1) and 2\u201312 weeks (T2) after initiation of fluid therapy were analyzed. Creatinine concentrations were analyzed as absolute values and as the maximum percentage change from T0 to T1 (T1max%) and from T0 to T2 (T2max%), respectively.<\/jats:p><jats:p>Creatinine concentrations were available for 192 dogs during T1 and 37 dogs during T2. The median cumulative dose of HES was 86 mL\/kg (range, 12\u2013336 mL\/kg). No difference was detected between the groups for age, gender, body weight, and length of hospitalization. Outcome was significantly different between the HES (66% survived) and the CRYS (87% survived) groups (<jats:italic>P<\/jats:italic>= 0.014). No significant difference was detected between groups for creatinine concentrations at T0, T1, T2, T1max%, or T2max%. No significant difference was detected between the groups for T1max% creatinine in dogs subclassified as having systemic inflammatory response syndrome or sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HES administration in this canine population did not result in increased creatinine concentrations compared to administration of CRYSs. Further studies are needed to establish the safety of HES in critically ill dogs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vec.12483","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T16:06:52Z","timestamp":1462378012000},"page":"568-577","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Retrospective evaluation of the effects of administration of tetrastarch (hydroxyethyl starch 130\/0.4) on plasma creatinine concentration in dogs (2010\u20132013): 201 dogs"],"prefix":"10.1111","volume":"26","author":[{"given":"Ivayla D.","family":"Yozova","sequence":"first","affiliation":[{"name":"Emergency and Critical Care Section, Small Animal Clinic, Department of Clinical Veterinary Medicine, Vetsuisse Faculty University of Bern Laenggassstrasse 124, 3012 Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Howard","sequence":"additional","affiliation":[{"name":"Diagnostic Clinical Laboratory, Department of Clinical Veterinary Medicine, Vetsuisse Faculty University of Bern Laenggassstrasse 124, 3012 Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja\u2010Nicole","family":"Adamik","sequence":"additional","affiliation":[{"name":"Emergency and Critical Care Section, Small Animal Clinic, Department of Clinical Veterinary Medicine, Vetsuisse Faculty University of Bern Laenggassstrasse 124, 3012 Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31820ad607"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-7241-21-66"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31827175da"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12281"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc9293"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2415-1"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070716"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209759"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.430"},{"key":"e_1_2_8_12_1","unstructured":"European Medicines Agency (EMA).Press release: hydroxyethyl\u2010starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients. Available at:http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Hydroxyethyl_starch\u2010containing_solutions\/human_referral_prac_000012.jsp&mid=WC0b01ac05805c516f 2013. Accessed September 23 2014."},{"key":"e_1_2_8_13_1","unstructured":"Department of Health and Human Services U.S. Food and Drug Adminitration (FDA). Press release: FDA Safety Communication: Boxed warning on increased mortality and severe renal injury and additional warning on risk of bleeding for use of hydroxyethyl starch solutions in some settings. Available at:http:\/\/www.fda.gov\/biologicsbloodvaccines\/safetyavailability\/ucm358271.htm 2013. Accessed September 23 2014."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.5326\/JAAHA-MS-5868"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2013.03.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12208"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12283"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.68.6.657"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.70.11.1345"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2995.2010.00589.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12188"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1996.tb02066.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2004.65.1189"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199103000-00015"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-4431.2005.00138.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03215.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jama.1967.03120050039007","article-title":"Treatment of massive hemorrhage with colloid and crystalloid solutions. Studies in dogs","volume":"199","author":"Takaori M","year":"1967","journal-title":"J Am Med Assoc"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-86502009000200003"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196611000-00017"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2460\/javma.1996.208.04.537","article-title":"Hospital\u2010acquired acute renal failure in dogs: 29 cases (1983\u20101992)","volume":"208","author":"Behrend EN","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-4431.2011.00689.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-8-248"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.13638"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-950X.1997.tb01699.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2001.62.948"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00433.x"},{"key":"e_1_2_8_37_1","first-page":"19","article-title":"Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.c6234"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2012.00985.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0063.x"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.10.044"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/82.4.510"},{"key":"e_1_2_8_44_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2460\/ajvr.1993.54.02.341","article-title":"Effect of deferoxamine\u2010hydroxyethyl pentafraction starch on free, autogenous full\u2010thickness skin grafts in dogs","volume":"54","author":"Hosgood G","year":"1993","journal-title":"Am J Vet Res"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995935"},{"key":"e_1_2_8_46_1","first-page":"965","article-title":"Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch","volume":"131","author":"Thompson WL","year":"1970","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc7726"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707163170306"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc7745"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/18.4.1031"},{"key":"e_1_2_8_51_1","article-title":"Graz","author":"Fresenius Kabi Austria","year":"2013","journal-title":"Full prescribing information for Voluven"},{"key":"e_1_2_8_52_1","unstructured":"Fresenius Kabi Austria. Graz.Full prescribing information for Hemohes 6%\u2010solution. Available at:http:\/\/www.pharmazie.com\/graphic\/A\/69\/1\u201024669.pdf 2002. Accessed November 06 2014."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-7241-21-61"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04211-2"},{"key":"e_1_2_8_55_1","first-page":"479730","article-title":"Epidemiology of acute kidney injury in the intensive care unit","volume":"2013","author":"Case J","year":"2013","journal-title":"Crit Care Res Pract"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01361.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1435-6935.2002.00025.x"}],"container-title":["Journal of Veterinary Emergency and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvec.12483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvec.12483","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vec.12483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T06:04:56Z","timestamp":1718517896000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vec.12483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/vec.12483"],"URL":"https:\/\/doi.org\/10.1111\/vec.12483","archive":["Portico"],"relation":{},"ISSN":["1479-3261","1476-4431"],"issn-type":[{"value":"1479-3261","type":"print"},{"value":"1476-4431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]},"assertion":[{"value":"2015-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}